Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 32Leukemia 26Melanoma 25Kidney Neoplasms 25Leukemia, Myeloid, Chronic-Phase 22Multiple Myeloma 17Lymphoma 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Neoplasms, Plasma Cell 13Lymphoma, Follicular 12Pancreatic Neoplasms 9Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Waldenstrom Macroglobulinemia 7Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myeloid, Accelerated Phase 6Carcinoma, Hepatocellular 6Colorectal Neoplasms 5Urinary Bladder Neoplasms 4Recurrence 4Rectal Neoplasms 4Lung Neoplasms 4Immunoglobulin Light-chain Amyloidosis 4

Interventions

Gemcitabine 30Mitomycin 25BCG Vaccine 13Docetaxel 10Epirubicin 6erdafitinib 5durvalumab 5dodecyl maltoside 5Radiotherapy 5Cystoscopy 5apaziquone 4ALT-803 4tislelizumab 35-aminolevulinic acid hexyl ester 3viscum album peptide 2pembrolizumab 2disitamab vedotin 2avelumab 2VB4-845 2Therapeutics 2Imiquimod 2Hyaluronic Acid 2Administration, Intravesical 21-phenyl-3,3-dimethyltriazene 2vocimagene amiretrorepvec 1valrubicin 1tremelimumab 1toripalimab 1pirarubicin 1pemigatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Muscle Invasive Bladder Neoplasms × Interferon-alpha × Clear all
NCT00330707 2011-03-04

Combined Use of BCG and Interferon Alpha in Bladder Cancer

National University Hospital, Singapore

Phase 2/3 Completed
140 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡